Sildenafil
NDC 82647-210, sildenafil, tablet, film coated, from Reyoung Corporation.
- Product NDC
- 82647-210
- Status
- Listed
- Labeler
- Reyoung Corporation
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208494
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82647-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILDENAFIL CITRATE25 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82647-210-14 | 82647021014 | 1000 TABLET, FILM COATED in 1 BOTTLE (82647-210-14) |
| 82647-210-30 | 82647021030 | 30 TABLET, FILM COATED in 1 BOTTLE (82647-210-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dc998a9c-0770-111b-e053-2a95a90a88a4
Use it
Look up 82647-210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82647-210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82647-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.